SABCS 2014: Estrogen Receptor Positive Treatments & More

The San Antonio Breast Cancer Symposium (SABCS) is one of the world’s premier forums on breast cancer prevention, screening and treatments. Leading experts on breast cancer from various backgrounds gather every year at the SABCS in an effort to promote discussion and education around current trends in breast cancer research.

Now in its 37th year, one of the major focuses of the 2014 SABCS will be on estrogen receptor positive breast cancer. For those interested in developments in this area and others, here is what to watch for.

San Antonio Breast Cancer Symposium 2014

Estrogen Receptor Positive Breast Cancers

In year’s past, HER2-positive breast cancers have been […]

Review of the 2013 SABCS

Bevacizumab | 2013 SABCS | BreastlinkThe San Antonio Breast Cancer Symposium (SABCS) is an annual international conference directed towards academicians, private physicians and researchers with more than 7,000 in attendance from 90 countries. The purpose of the symposium is to relay breaking news, trial updates, advances in biology and practice-changing guidelines in breast cancer care and management.

Breastlink sends a team of physicians and researchers to SABCS every year to gather critical updates and research advances. We then disseminate the results to patients, referring physicians and the Breastlink medical team. Last year, for example, the results of the ATLAS trial delivered at the 2012 […]

By | February 3, 2014|Categories: Cancer News, Cancer Research|Tags: , |0 Comments

SABCS 2013 – Anastrozole

The 2013 San Antonio Breast Cancer Symposium was an engaging and invigorating event – I look forward to sharing what I have learned with colleagues and patients. If you have any specific questions you would like me to address about this year’s Symposium please feel free to leave a comment to this blog post or contact my office.

Dr. Nimmi Kapoor and I will also be sharing our observations from this year’s San Antonio Breast Cancer Symposium in a series of community lectures in January. We will share details when they are confirmed.

Here are a few observations from the plenary sessions I attended on Thursday and Friday.

Anastrozole May Provide New Option […]

By | December 17, 2013|Categories: Cancer Research, Oncology|Tags: , |0 Comments

2013 SABCS: Bisphosphonate Therapy | Anastrozole

The 2013 San Antonio Breast Cancer Symposium (SABCS) presented many studies that will change how medical professionals screen, diagnose and treat for breast cancer. The following are a few observations from the SABCS 2013 I think women and fellow medical professionals might be interested in.

Adjuvant Bisphosphonate Therapy in Breast Cancer

The meta-analysis of bisphosphonate treatment presented on Thursday will be practice changing. The Overview Analysis evaluated the benefit of bisphosphonates (such as Zometa) in all randomized trials including more than 17,000 women with breast cancer with 15-year follow-up.

Bisphosphonates given at the start of treatment to post-menopausal women with breast cancer can decrease bone recurrence by 34 percent and can significantly decrease […]

By | December 16, 2013|Categories: Cancer Research, Oncology|Tags: |0 Comments

2013 SABCS Wed. Screening & Surgical Insights

The first day of the 2013 San Antonio Breast Cancer Symposium (SABCS) featured the findings of a few breast cancer screening studies in the morning. The afternoon sessions discussed interesting results from surgical trials and updates on managing the axilla. Here are a few observations from the deliberations of Wednesday, December 11.

2013 San Antonio Breast Cancer Symposium Wednesday Morning Observations

Although the benefit of mammography on decreasing late stage cancer presentation are under question the overall decrease in breast cancer mortality is undeniable and commendable.

One study evaluated the benefit of screening MRI on average risk patients showing an increase in cancer detection in 11 women per 1000 screened. All cancers were […]

By | December 12, 2013|Categories: Breast Surgery, Cancer Research|Tags: |0 Comments

2013 SABCS Wednesday Oncology Observations

The inaugural day of the 2013 San Antonio Breast Cancer Symposium introduced new insights with treatment implications. I believe patients diagnosed with HER2-positive breast cancer(s) will find of two studies of particular interest:

NeoALTTO Trial (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimization). This is an ongoing phase III clinical trial that is evaluating if a combination of trastuzumab and lapatinib (two HER2-targeted therapy agents) is better than only one of the HER2-targeted therapies. The published findings showed a moderate benefit to adding lapitinib (tykerb) to trastuzumab (herceptin) prior to surgery while significantly increasing side effects.

The same research team will present the results of the ALTTO trial (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization) at the […]

By | December 12, 2013|Categories: Cancer Research, Oncology|Tags: |0 Comments

A Year in Reflection—Excited about the 2013 SABCS

A year in reflection—excited about the 2013 San Antonio Breast Cancer Symposium.

I love my job. As a breast cancer surgeon with Breastlink, I have many roles. I get to take care of patients, who, even if they don’t realize it, take care of me, too. They inspire me probably more than I can ever help them.

“It’s only cancer,” said one of my heroes, “at least I can go to a doctor and get it taken care of.” Or, “Chemo is okay. At least I can still work, a little,” said another one of my heroes. My patients often thank me, but really it is I who am quietly thanking them […]

By | December 11, 2013|Categories: Cancer Research|Tags: |0 Comments

2013 SABCS Preview

A guest blog post from Breastlink Research Development Manager Barbara Stankova.

This is an exciting time in breast cancer research and treatment. We are nearing an era where we can help patients with personalized therapies that specifically target the genetic profile of a patient’s breast cancer tumor(s). The ability to only target cancerous tumors will lead to treatment options that are far more effective – and successful – than traditional breast cancer treatment options.

One of the most motivating annual events for breast cancer advocates and researchers is the San Antonio Breast Cancer Symposium (SABCS). Not only are some of the most significant research findings announced during the five day event, it […]

By | December 10, 2013|Categories: Cancer Research|Tags: |0 Comments

Irvine Breast Cancer Educational Meeting 3/20 | SABCS Update

Irvine Breast Cancer Educational Meeting with Update from the 2012 San Antonio Breast Cancer Symposium

Breastlink Breast Surgical Oncologist Nimmi Kapoor M.D. to Share Insights

IRVINE, Calif., March 11, 2013 – Breastlink Medical Group (Breastlink), a network of comprehensive breast health centers, announced Breast Surgical Oncologist Nimmi Kapoor, M.D. will provide a free, public talk covering key findings from the 2012 San Antonio Breast Cancer Symposium (SABCS) on Wednesday, March 20 at the Hoag Hospital Irvine Auditorium in Irvine. Dr. Kapoor attended the 2012 SABCS, which was held December 4-8, 2012 in San Antonio, Texas.

“The San Antonio Breast Cancer Symposium (SABCS) is one of the most highly esteemed breast cancer conferences […]

By | March 11, 2013|Categories: Press Releases|Tags: |0 Comments
Load More Posts